Integrated Diagnostics Holdings plc Stock

Equities

IDHC

JE00BLKGSR75

Healthcare Facilities & Services

Market Closed - London S.E. 11:35:08 2024-04-19 am EDT 5-day change 1st Jan Change
0.35 USD -0.71% Intraday chart for Integrated Diagnostics Holdings plc -5.02% -1.41%
Sales 2024 * 5.42B 112M Sales 2025 * 6.55B 136M Capitalization 10.15B 210M
Net income 2024 * 822M 17.03M Net income 2025 * 982M 20.34M EV / Sales 2024 * 1.79 x
Net cash position 2024 * 438M 9.07M Net cash position 2025 * 982M 20.34M EV / Sales 2025 * 1.4 x
P/E ratio 2024 *
13 x
P/E ratio 2025 *
9.08 x
Employees 6,692
Yield 2024 *
6.17%
Yield 2025 *
8.82%
Free-Float 51.88%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Integrated Diagnostics Holdings plc

1 day-0.71%
1 week-5.02%
Current month-11.39%
1 month-10.60%
3 months-2.91%
6 months-19.35%
Current year-1.41%
More quotes
1 week
0.35
Extreme 0.35
0.37
1 month
0.35
Extreme 0.35
0.40
Current year
0.29
Extreme 0.29
0.43
1 year
0.29
Extreme 0.29
0.63
3 years
0.29
Extreme 0.29
1.45
5 years
0.29
Extreme 0.29
1.45
10 years
0.29
Extreme 0.29
1.85
More quotes
Managers TitleAgeSince
Chief Executive Officer 55 11-12-31
Director of Finance/CFO - Jan. 17
Investor Relations Contact - -
Members of the board TitleAgeSince
Chairman 66 15-01-11
Director/Board Member 58 15-01-11
Director/Board Member 59 14-12-22
More insiders
Date Price Change Volume
24-04-19 0.35 -0.71% 7,510
24-04-18 0.3525 -0.98% 9,840
24-04-17 0.356 -1.66% 7,121
24-04-16 0.362 -0.69% 24,533
24-04-15 0.3645 -1.09% 779,877

Delayed Quote London S.E., April 19, 2024 at 11:35 am EDT

More quotes
Integrated Diagnostics Holdings PLC is a consumer healthcare company. The Company operates in the Middle East and Africa with operations in Egypt, Jordan, Sudan and Nigeria. The Company is engaged in offering services in immunology, microbiology, hematology, endocrinology, clinical chemistry, molecular biology, histopathology, genetics, radiology and others. The Company’s brands include Al Borg Scan, Al Mokhtabar, Ultralab, Biolab, Echo-Lab and others. It operates in approximately 552 branches. It offers more than 3,000 diagnostics tests ranging from routine to advanced. Its common tests include those for cholesterol, diabetes, pregnancy and substance abuse. Through Al Borg Scan, it offers a full range of radiology services, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography-computed tomography (PET-CT), electromyography (EMG), electrocardiogram (ECG), electroencephalogram (EEG), ultrasound, x-ray, mammograms and cath lab facilities.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
16.92 EGP
Average target price
32.81 EGP
Spread / Average Target
+93.95%
Consensus

Quarterly revenue - Rate of surprise